HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors.

AbstractOBJECTIVE:
To investigate the expression of bone resorption regulators (receptor activator of nuclear factor kappa B [RANK], RANK ligand [RANKL], and osteoprotegerin [OPG]) in calcifying cystic odontogenic tumor (CCOT), adenomatoid odontogenic tumor (AOT), calcifying epithelial odontogenic tumor (CEOT), odontogenic myxoma (OM), and ameloblastic fibroma (AF).
STUDY DESIGN:
The expression of these mediators was evaluated by means of immunohistochemistry.
RESULTS:
All specimens demonstrated positive immunoreactivity to RANK, RANKL, and OPG. The quantification of these mediators in epithelium revealed a similar pattern of expression for RANKL and OPG in CCOT, AOT, CEOT, and AF. With regard to stromal/mesenchymal cells, the majority of AOT and CCOT cases showed a higher content of OPG than RANKL, whereas CEOT, OM, and especially AF had a tendency to present a greater content of RANKL than OPG.
CONCLUSION:
Our data indicate that the CCOT, AOT, CEOT, OM, and AF cell constituents express key regulators of bone metabolism that might locally modulate tumor-associated bone resorption.
AuthorsFlávia R Andrade, Débora P Sousa, Elismauro F Mendonça, Tarcília A Silva, Vanessa S Lara, Aline C Batista
JournalOral surgery, oral medicine, oral pathology, oral radiology, and endodontics (Oral Surg Oral Med Oral Pathol Oral Radiol Endod) Vol. 106 Issue 4 Pg. 548-55 (Oct 2008) ISSN: 1528-395X [Electronic] United States
PMID18928898 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Osteoprotegerin
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
Topics
  • Adult
  • Alveolar Bone Loss (etiology, metabolism)
  • Female
  • Humans
  • Immunohistochemistry
  • Jaw Neoplasms (chemistry, complications, metabolism)
  • Male
  • Odontogenic Tumors (chemistry, complications, metabolism)
  • Osteoclasts (metabolism)
  • Osteolysis (etiology, metabolism)
  • Osteoprotegerin (biosynthesis)
  • RANK Ligand (biosynthesis)
  • Receptor Activator of Nuclear Factor-kappa B (biosynthesis)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: